HealthEquity is rated a Buy with a $115 price target, supported by catalysts, margin gains, and share buybacks. Read more on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results